What is Innoviva, Inc.'s SG&A?

Innoviva, Inc. (INVA) reported SG&A of $32.44M in Q1 2026.

How has Innoviva, Inc.'s SG&A changed year-over-year?

Innoviva, Inc.'s SG&A increased by 18.0% year-over-year, from $27.49M to $32.44M.

What is the long-term trend for Innoviva, Inc.'s SG&A?

Over 3 years (2022 to 2025), Innoviva, Inc.'s SG&A has grown at a 21.3% compound annual growth rate (CAGR), from $63.54M to $113.32M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Innoviva, Inc. INVA SG&A

SG&A at other companies

PfizerPFE

$2.96B-2.3%

Merck & Co.MRK

$2.7B+5.8%

AbbVieABBV

$3.58B+8.7%

InsmedINSM

$247.26M+67.6%

AlkermesALKS

$264.59M+54.1%

OrganonOGN

$424M+1.0%

Other financials

Income statement

See full

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

See full

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

See full

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

See full

Market cap$1.74B+51.8%

Enterprise value$1.41B+9.7%

P/E3.5×—

P/S4.2×+1.0×

Profitability

See full

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

See full

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innoviva, Inc.'s SG&A?: Innoviva, Inc. (INVA) reported SG&A of $32.44M in Q1 2026.
How has Innoviva, Inc.'s SG&A changed year-over-year?: Innoviva, Inc.'s SG&A increased by 18.0% year-over-year, from $27.49M to $32.44M.
What is the long-term trend for Innoviva, Inc.'s SG&A?: Over 3 years (2022 to 2025), Innoviva, Inc.'s SG&A has grown at a 21.3% compound annual growth rate (CAGR), from $63.54M to $113.32M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.